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Abstract 
Chronic stress is the principal component to many human and animal disorders. As stress 
responses are remarkably conserved between mammals and teleosts, the use of teleosts in 
comparative models has been a useful tool in neurobiology. In particular, salmonid fishes 
have emerged as model organisms for chronic social stress due to their well-characterized 
social behavior and physiology.  
The serotonergic system is involved in a wide variety of functions, among which are the 
control of the neuroendocrine stress response and the regulation of an array of behaviors such 
as feeding and aggression. In salmonid models of chronic social stress, serotonergic activity 
in subordinate individuals has been found to be elevated in many brain regions, in some 
instances to pathological levels. In this study, the serotonergic system of Atlantic salmon was 
pharmacologically activated with fluoxetine for 18 days and the behavioral, physiological and 
neurochemical responses were examined. Fluoxetine induced anorexia, surfacing behavior 
and an increased tendency for treated fish to position themselves in a head up, tail down 
position. Physiologically, fluoxetine treated salmon had increased brain stem serotonergic and 
norepinephrine activity, greatly elevated cortisol levels, larger relative heart sizes, upregulated 
hypothalamic AVT and 5-HT1Aβ receptor mRNA levels. All of these behavioral and 
physiological parameters are strikingly similar to those exhibited by subordinate salmonids in 
chronic social stress models.  These results indicate that long term pharmacological activation 
of the serotonergic system in Atlantic salmon recapitulates many of the typical behavioral and 
physiological markers found in salmonid models of chronic social stress. The utilization of 
fluoxetine and other pharmacological tools to manipulate serotonergic signaling may thus be 
of further use in elucidating the intricacies of the stress response and mechanisms that lead to 
its dysfunction. 
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1 Introduction 
 
Organisms that face a perceived threat to their biological functions activate an array of 
behavioral and physiological mechanisms to fulfill a current or anticipated demand and thus 
improve their chances of survival. These perceived threats, both internal and external are 
termed “stressors”1 and the mechanisms that are activated, such as the sympathetic-adrenal 
medullary (SAM) or the hypothalamic-pituitary-adrenal (HPA) axis have become widely 
known as the neuroendocrine stress response. It has however been argued recently, that the 
activation of mechanisms comprising the stress response, may not only be elicited under 
stressful situations. In fact, these mechanisms may also be activated under  non-aversive or 
harmful situations, such as increased metabolic demand during behavioral activity2,3. 
Therefore, Koolhaas4 proposes a more restricted definition of stressors as “conditions where 
an environmental demand exceeds the natural regulatory capacity of an organism, in 
particular situations that include unpredictability and uncontrollability”. Notably, 
unpredictability and uncontrollability are particularly potent factors in stress-induced 
pathology5,6 as well as being important variables in determining the success of behavioral 
strategies7. Hence with these concepts in mind, I have chosen to adhere to Koolhaas’s 
working definition of stress in this thesis.  
As stress is a risk factor for a variety of human and animal disorders, such as mood disorders8 
and cardiovascular disease9, the stress response and its regulation is of considerable research 
interest. Inadequate, excessive and/or prolonged activation of the stress response can itself be 
damaging and lead to a reduced ability to cope with stressors4. In particular, stress responses 
sustained over long periods have been shown to cause alterations at various levels  of the 
stress response pathways10–12. In addition, the behavioral response to stressors varies between 
individuals6 and can change depending on the severity and/or duration of the stressor. For 
example,  severe or prolonged (chronic) stress, may bias individuals from active behavior 
(proactive) to behavioral inhibition (reactive)13–15. In this respect, it has been proposed that a 
stress-induced switch to reactive behavior is adaptive in unpredictable environments, while 
proactive behavior is more suited to stable environments6,7. 
One common paradigm utilized in both mammalian and teleost models in order to study the 
effects of acute and chronic stress is subordination, i.e. defeat stress16–19. Under these 
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conditions, the subordinate may experience unpredictable and unilateral aggression from the 
dominant over extended periods of interaction17. 
1.1 Fish as models for chronic stress: Social subordination in salmonids 
 
Salmonid fish have been used in neurobiological research as a model for social stress due to 
their well characterized behavioral, physiological and neuroendocrine responses to social 
subordination20–22. Exploiting the normally territorial nature of salmonids, interaction of a 
subordinate fish with a dominant leads to behavioral and physiological changes in the stressed 
subordinate that are similar to those found in mammalian models16. For example, subordinate 
salmonids display a reduced feeding intake, elevated plasma cortisol, serotonergic activity 
and decreased expression of brain neuroplasticity markers17,23–26. Furthermore, in the brain, 
the increase in serotonergic activity appears to include the hypothalamus, telencephalon and 
brain stem, and may last over several weeks (so long as the subordinate is kept together with 
the dominant)17,20. Notably, the reduced feeding in subordinates is not due to interference or 
continued aggression by the dominant conspecific as it persists after the subordinate has been 
isolated. In fact, the reduced feed intake recovers gradually after separation of the 
dominant/subordinate pair, during which time, there is also a decline in serotonergic activity  
back to baseline24. Interestingly, Vindas et. al.27 recently characterized a neuroendocrine 
phenotype in farmed Atlantic salmon (Salmo salar) where individuals which had been 
subjected to chronic social stress displayed an elevated level of serotonergic activity and an 
inability of the serotonergic system to respond further to acute stress, despite showing a 
functional cortisol stress response. This illustrates that serotonergic dysfunction can be found 
in fish undergoing severe and prolonged stress. 
1.2 The Neuroendocrine Stress Response 
 
The neuroendocrine stress response in both mammals and teleosts, is activated and regulated 
in a similar manner. This response consists of the activation of two main systems:  
 The rapid sympathetic-adrenal medullary (SAM) system (sympathetic-chromaffin in 
fish) 
 
 The slower hypothalamic-pituitary-adrenal (HPA) axis (hypothalamic-pituitary-
interrenal (HPI) axis in fish) 
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The SAM response is initiated by the sympathetic nervous system and its main effect is to 
promote the release of pre-synthesized epinephrine and norepinephrine into the bloodstream 
from the adrenal medulla (or chromaffin cells of the head kidney in fish). This results in 
mobilization of energy stores into the bloodstream, improved capacity of red blood cells to 
carry oxygen and increased cardiovascular function28,29. 
Activation of the HPA axis begins in the hypothalamus with the release of Corticotropin 
Releasing Hormone (CRH). CRH stimulates release of Adrenocorticotropic Hormone 
(ACTH) from the anterior pituitary into the bloodstream. ACTH in turn stimulates cortisol 
secretion from the adrenal cortex (or interrenal cells in fish). In addition, neuropeptides such 
as Arginine Vasopressin (AVP) may also contribute directly and/or indirectly, by potentiating 
the release of ACTH and cortisol. Cortisol in turn exhibits negative feedback on all levels of 
the HPA/HPI axis30. 
The transcriptional effects of cortisol are classically mediated through corticosteroid 
receptors, which are ligand-binding nuclear receptors. Cortisol being highly lipophilic, 
diffuses freely through the plasma membrane into the cytosol.  In mammals, a high affinity 
(10-fold higher) Mineralocorticoid Receptor (MR) and a lower affinity Glucocorticoid 
Receptor (GR) have been described to bind cortisol. Ligand-bound corticosteroid receptor 
dimers in the nucleus bind to Glucocorticoid Response Elements (GREs) in the promoter 
region of target genes and may activate or repress transcription, depending on the GRE. In 
salmonids, one high affinity MR homologue and two lower affinity GR homologues (GR1 
and GR2) have been described, with GR2 showing a higher cortisol affinity31.  
1.3 Serotonergic Transmission and Control of the Stress Response 
 
Serotonin (or 5-hydroxytryptamine, 5-HT) is a major monoamine neurotransmitter and 
neuromodulator in the central nervous system (CNS). Because the serotonergic system is 
evolutionarily very ancient, much homology can be found between the molecular, cellular, 
anatomical, and functional components between mammals and teleosts. For example, many 
proteins involved in the serotonergic system first identified in mammalian models have been 
now cloned and characterized in zebrafish (Danio rerio) such as the 5-HT transporter (SERT) 
and the 5-HT synthesis enzyme tryptophan hydroxylase (TPH)32. The functionality of 
serotonergic transmission in mammals and teleosts also bear much similarity to each other33, 
although differences have been found. For example, in teleosts there is the presence of 
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additional clusters of serotonergic cell bodies34 and differential expression of specific 
isoforms of SERT35. 
Serotonergic cell bodies are found in multiple clusters mainly distributed throughout the mid 
and hindbrain, which send projection axons to all other regions of the brain. This in turn,  can 
release 5-HT both at the axon terminals and along the axon36. In zebrafish, the best 
characterized teleost, additional clusters of serotonergic neurons are found in the 
hypothalamus, pre-optic area and posterior tuberculum33. Because 5-HT receptors are also 
often found extrasynaptically, and 5-HT can act through volume transmission, the wide 
distribution of serotonergic fibers allows for an extensive serotonergic regulation throughout 
the brain on specific neurons that express the appropriate receptors. Accordingly, serotonergic 
transmission plays a role in very diverse functions, which include housekeeping tasks like 
thermoregulation and food intake37, more complex physiological regulation such as that of the 
generalized stress response38 and also behavioral responses and affective states, such as 
aggression and anxiety-like behavior30. 
The ratio of the concentration of 5-Hydroxyindoleacetic acid (5-HIAA; which is the main 
catabolite for 5-HT) over the total concentration of 5-HT, i.e. [5-HIAA]/[5-HT], is commonly 
taken as a measure of serotonergic activity in a particular brain area39. In brief tissue 
concentrations of 5-HT may not be sufficient to adjudge serotonergic activity, since it is not 
possible to distinguish between actively signaling 5-HT in the extracellular space, vesicle-
bound intracellular and/or cytoplasmic free 5-HT. However, as vesicle-bound 5-HT is 
protected from monoamine oxidases (MAO) located in the outer mitochondrial membrane40, 
the catabolite 5-HIAA is generated only from cytoplasmic 5-HT. Therefore, all other 
parameters being equal, a higher concentration of actively signaling extracellular 5-HT leads 
to increased reuptake by the 5-HT transporter located in the plasma membrane, leading to an 
increased cytoplasmic concentration of 5-HT and thus increased substrate availability for 
MAO. However, the [5-HIAA]/[5-HT] ratio may be affected not just by normal 5-HT 
turnover from activity, but also from factors such as MAO activity, synthesis rates and by 
reuptake blockers such as fluoxetine. Furthermore, MAO40 and TPH241 activity are known to 
be regulated by glucocorticoids and therefore may also perturb this ratio. 
5-HT receptors are a very diverse family of membrane receptors found both in the CNS and 
other tissues. Presently 14 receptors, classified into 7 families based on their pharmacology, 
signal transduction and structure, have been found, and with the exception of the 5-HT3 type, 
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all of them are G-protein coupled receptors (GPCRs)42. The 5-HT1A receptor in the CNS is 
well described as being involved in affective disorders and is present as both a heteroreceptor 
on non-serotonergic target neurons (such as hippocampal neurons) and as a somatodendritic 
autoreceptor on serotonergic neurons43. 5-HT1A autoreceptors inhibit firing of serotonergic 
neurons by hyperpolarization through G-protein-coupled inwardly-rectifying potassium 
channels (GIRK), and therefore have influence on all serotonergic transmission43. 
Postsynaptically, 5-HT1A and 5-HT2C receptors have been shown in mammals and teleosts to 
control cortisol release30, thus illustrating a direct coupling of the serotonergic system to 
stress-induced activation of the HPA/HPI axis. 
1.4 Pharmacological Activation of the Serotonergic System 
 
The time course of serotonergic response in various brain regions to social subordination in 
salmonids have been thoroughly described by Øverli et al.23.Furthermore, along with the 
serotonergic response, other consequences of subordination have been described, such as 
elevated plasma cortisol and reduced feeding behavior44. Pharmacologically, in mammals and 
fish, the use of 5-HT receptor agonists has been successfully utilized for the study of the link 
between 5-HT receptors  to the HPI axis44–47 and feeding behavior34,37,48. However, as these 
studies used short-duration selective agonists for specific receptor subtypes, it is thus not 
possible to compare their effects to the generalized upregulation of serotonergic signaling 
sustained over several days  found in salmonid chronic social stress models17,20,25. It is hence 
of interest to study the long term effects of a more generalized activation of the serotonergic 
system in salmonid fish as it is the serotonergic correlate of chronic stress and may reveal 
alteration in serotonergic signaling that precede dysfunction. 
Fluoxetine is a selective 5-HT reuptake inhibitor (SSRI) that inhibits the major 5-HT reuptake 
pump, SERT, in the brain. This causes an increase in the extracellular concentration of 
actively signaling 5-HT, mimicking the effects of increased serotonergic activity. Notably, in 
ecotoxicology49,50 as well as experimental studies32,51, fluoxetine has been found to be 
effective as an SSRI in teleosts. Furthermore, fluoxetine also has the longest half-life (2 days 
in humans) of the SSRIs52, allowing for a more infrequent administration which makes it 
practical in experimental settings to diminish the possible stress caused by drug 
administration. The possible role of fluoxetine as a pharmacological tool to investigate 
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behavioral and physiological effects of chronic 5-HT activation has however not been 
explored in the salmonid fish model. 
This study was conducted on Atlantic salmon because the relatively stress-sensitive nature of 
this salmonid species might allow for larger effects to be seen compared to relatively stress-
tolerant species such as rainbow trout (Oncorhynchus mykiss). In addition, Vindas et. al.27 
recently found serotonergic dysfunction in a chronically stressed subpopulation of farmed 
Atlantic salmon, thus confirming that chronic stress may result in alterations of serotonergic 
regulation in salmonids. In the present study I therefore administered fluoxetine to Atlantic 
salmon for 2 weeks in order to activate serotonergic signaling, mimicking the serotonergic 
effects of chronic social stress. Data on behavioral, physiological and neurochemical 
parameters related to serotonergic activity and the neuroendocrine stress response were 
quantified here and I compared my results with those reported by research on salmonid social 
stress models.  
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2 Aims of Study 
 
The aims of this study are: 
• To test an oral “stress-free” method of fluoxetine administration on isolated Atlantic 
salmon over 2 weeks.  
• To verify drug effects on serotonergic signaling in Atlantic salmon.  
• To quantify the behavioral, physiological and neurochemical response to fluoxetine 
treatment over 2 weeks and compare neurobiological/behavioral profiles to those 
reported in salmonid chronic social stress models. 
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3 Materials and Methods 
3.1 Experimental Animals and Location 
 
Atlantic salmon from the Department of Animal and Aquacultural Sciences (University of 
Life Sciences, Ås, Norway) were transferred on the 12th of June to a 1250L tank at the fish 
holding facility at the Department of Biosciences, University of Oslo.. The tank was 
continuously supplied with dechlorinated Oslo tap water (1000L h-1) and aerated with bubbled 
air. During the holding period and throughout the experiment, the water temperature was 
between 8.5-10⁰C, dissolved oxygen content was 85-95% and the light regime was 12/12 
light/dark. Fish were hand fed with 3 mm commercial food pellets (Skretting, Norway) 
3.2 Pre-experimental Procedure 
 
Eight 250L glass aquaria, covered on 3 sides with opaque black plastic, were divided into 4 
compartments each, by PVC walls, forming 32 compartments in total. Each compartment was 
continuously supplied with dechlorinated Oslo tap water (5L h-1) and aerated with bubbled 
air. Waterproof video cameras (Colour CCD cameras, IR- YC-25V, with a 3.6 mm lens) 
controlled by an MSH-video multicam surveillance system (M. Shafro & Co., Riga, Latvia), 
were placed approximately 70cm in front of each aquaria.    
 
Atlantic salmon were transferred and isolated on the 16th of August from the group holding 
tank. Fish were hand fed daily 10 dry pellets between 1300 and 1500. Feeding behavior was 
assessed and scored daily  by observing the response of the fish to food items dropped one by 
one into the tank, according to the following scale (modified from Sørensen et. al.25): 
• 0 – Fish does not respond to food, even when dropped directly in front of it. 
• 1 – Fish only eats pellets that fall directly in front of it. 
• 2 – Fish moves less than half body length to eat food, ignores otherwise. 
• 3 – Fish moves to eat food throughout the tank, but returns to original position each time. 
• 4 – Fish swims actively after food items throughout the tank. 
Individuals were acclimated for a period of 5 weeks until full feeding behavior (scored 4 on 
the feeding scale) was observed (a total of 1 individual was excluded). 
Following the acclimatization period, fish were weighed by anesthetizing them lightly in 
50mg/L MS-222 (Syndel Laboratories Ltd, BC, Canada). Thereafter, fish were fed with dry 
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pellets once every second day with a ration corresponding to 0.05% of their body weight. In 
addition, fish were fed small quantities of dried shrimp hydrated in deionized water over 9 
days, in order to acclimatize them to this type of food (which was later used to administer 
fluoxetine, as explained further below). 
3.3 Preparation of Drugs 
 
Fluoxetine solution was prepared by dissolving 4 mg fluoxetine hydrochloride (Sigma-
Aldrich, St. Louis, MO, USA) per ml of deionized water. In addition, a control solution 
containing only deionized water was also prepared. Both solutions were placed into identical 
tubes and were administered blindly (the identity of each tube was marked by a person not 
involved in handling of the fish). Solutions were stored at -20⁰C in the dark. 
Prior to feeding, approximately 10g of dried shrimp were reconstituted in fluoxetine or 
control solutions for 2hrs at room temperature. The weight of the shrimp after reconstitution 
was recorded and used to calculate the ration quantity for each fish that would result in the 
delivery of 4 ug/g body weight of fluoxetine, following the formula:  
Shrimp ration = 0.001 (Shrimp Wet Weight x Fish Weight) / (Shrimp Wet Weight - Shrimp Dry Weight) 
For intraperitoneal (i.p.) injections, 0.9% w/v sodium chloride (Sigma-Aldrich) was added to 
the fluoxetine and control solutions and vortex-mixed until completely dissolved. 
3.4 Experimental Procedure 
 
 
Figure 1: Timeline of Experiment. Feeding responses were assessed on every marked day before sampling. 
Tanks were assigned randomly to each of the two treatments. Fish were fed once every 2 days 
at 0.05% body weight with pelleted food for the first 9 days of the experiment. Fluoxetine-
shrimp rations were given on days 0, 5, 7, and 9 as shown on Figure 1. The spacing between 
the first and second doses (days 0 and 5 of experiment) was due to a logistics issue. 
Subsequently, all fish were fed 1 pellet every 2 days to assess feeding behavior. The feeding 
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amount was reduced to minimize discrepancy between normally eating fish and individuals  
which had developed varying readiness to accept food. On days 11, 13, 15, and 17 of the 
experiment, fish were lightly anesthetized with 50mg/L MS-222 and a drug solution amount 
corresponding to 4ug/g body weight was delivered via i.p. 2 hours after feeding. All fish were 
monitored after injection to ensure that they recovered properly from the handling and the 
anesthetic. The order of feeding and injections were randomized. 
3.5 Sampling 
 
On the last day of the experiment, fish were sampled in random order. Following rapid 
anesthetization in 800mg/L MS-222, fish were weighed and blood was collected from the 
caudal vein before the fish were sacrificed by decapitation and the brains and hearts dissected. 
Blood collection was done with 1 ml syringes containing the anticoagulant 
ethylenediaminetetraacetic acid (EDTA), and kept on ice for no more than 3 minutes before 
centrifugation at 4⁰C and 8000g, for 5 min. Blood plasma was then quickly frozen on dry ice 
and stored at -80⁰C. The brains were quickly excised (within 2 min) and  further divided into 
brain stem, which was snap frozen in liquid nitrogen and stored at -80⁰C, hypothalamus and 
pituitary, which were placed separately on RNA later® (Ambion, Austin TX, USA), and the 
telencephalon which was placed in 4% paraformaldehyde in phosphate buffered saline. Hearts 
were dissected and ventricles (after atrium and bulbus removal) were placed on previously 
weighed RNA later® Eppendorf tubes and reweighed. All tissues in RNA later® were kept at 
20⁰C for 1 day according to manufacturer’s instructions and subsequently stored at -20⁰C. 
3.6 RNA extraction and Quantitative PCR 
 
Total RNA was extracted from the hypothalamus using Trizol® reagent (Invitrogen, 
Carlsbad, CA, USA) extraction, according to manufacturer`s protocol. In short, samples were 
thawed, weighed and homogenized with 15µl/mg Trizol®. Extracted total RNA was treated 
with DNAse using a TURBO DNA-freeTM Kit (Ambion, Austin TX, USA) according to 
manufacturer’s instructions to remove DNA contamination. The RNA concentration was then 
quantified using the Nanodrop ND-2000 UV-Vis Spectrophotometer (Thermo Fisher 
Scientific Inc., Wilmington, DE, USA). RNA work was carried out on ice and stored at -
80⁰C. 12 out of 27 RNA samples were randomly selected and RNA quality checked using the 
Bioanalyzer 2100 (Agilent Technologies Inc. The RIN scale assigns a number between 1 and 
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10 to RNA samples, with 10 indicating intact RNA. All samples scored between 9.9-10 on the 
RIN scale, which confirmed excellent RNA quality.  
1µg of total RNA was reverse-transcribed into cDNA using OligodT18-20 primers (Invitrogen) 
and Superscript® III (Invitrogen) in a total volume of 20ul. The reaction was diluted 20X 
with nuclease free water and stored at -20⁰C. 
Quantitative PCR was carried out using 1uM of forward and reverse primers in 1 x  SYBR® 
GREEN I Master Mix (Roche Diagnostics, Basel, Switzerland) with 3µl of 1:20 cDNA as the 
template. Total reaction volume was 10µl. The reactions were run on a Lightcycler® 96 
(Roche Diagnostics). Cp values were obtained from the Lightcycler® 96 software (Roche 
Diagnostics). Primer efficiencies were calculated per primer pair, per reaction plate by using 
Linreg software (version 2012.1), according to the florescence values recorded during the 
amplification cycles. All samples were run in triplicates. Primer information is shown in 
Table 1 below. 
Table 1: Primer pairs used in Quantitative PCR 
Gene Primer Sequence 5’  3’ References 
AVT Fwd   GAGGGGATGGGCTGCTATGT 
Rev    CAAACCGCCCATTAAGGCAG 
Thörnqvist P-O. & Winberg S. Unpublished   
CRH Fwd   AACCAGCTCGACGACTCGATGG 
Rev    GCTATGGGCTTGTTGCTGTAACTG 
Nilsen T. O. & Ebbesson, L. O. E. Unpublished  
MR Fwd    AGACTCGACCCCCACCAAG   
Rev     CGTTAGTGGGACTGGTGCTC 
Kiilerich et al. 201153 
GR1 Fwd   ACGACGATGGAGCCGAAC   
Rev    ATGGCTTTGAGCAGGGATAG 
Kiilerich et al. 201153 
GR2 Fwd   TGGTGGGCTGCTGGATTTCTGC   
Rev    CTCCCTGTCTCCCTCTGTCA 
Kiilerich et al. 201153 
SERTa Fwd   ACAAACCACTCCCTCCTCCT 
Rev    CGGCTACATGGCTGAAATGC 
Thörnqvist P-O. & Winberg S. Unpublished   
5-HT1Aα Fwd   ATGCTGGTCCTCTACGGGCG 
Rev    CGTGGTTCACCGCGCCGTTT 
Thörnqvist P-O. & Winberg S. Unpublished   
5-HT1Aβ Fwd   TTGATCATGCGTTCCCAGCCGA 
Rev    AAAGGAATGTAGAACGCGCCGA 
Thörnqvist P-O. & Winberg S. Unpublished   
PCNA (Proliferating Cell 
Nuclear Antigen) 
Fwd   TGAGCTCGTCGGGTATCTCT 
Rev     CTCGAAGACTAGGGCGAGTG 
Vindas et al. 201454 
BDNF (Brain Derived 
Neurotrophic Factor) 
Fwd  ATGTCTGGGCAGACCGTTAC 
Rev    GTTGTCCTGCATTGGGAGTT 
Vindas et al. 201454 
 
EF1α (Elongation Factor-1α) 
Reference Gene 
Fwd    CCCCTCCAGGACGTTTACAAA 
Rev    CACACGGCCCACAGGTACA 
Ingerslev et al. 200655 
 
3.7 Brain stem Neurochemistry 
 
Frozen brain stems were homogenized in 4 % (w/v) ice cold perchloric acid (PCA) containing 
0.2% EDTA and 3,4-dihydroxybenzyl amine hydrobromide (DHBA, 40 ng/ml) as an internal 
standard using a Potter–Elvehjem homogenizer. After spinning samples for 10 min at 13000 
rpm and 4°C, the supernatant was analyzed by means of high-performance liquid 
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chromatography (HPLC). The mobile phase was made up of 12 µM EDTA, 86 mM sodium 
phosphate and 1.4 mM sodium octyl sulphate in deionized water (resistance 18.2 MW), 
containing 7 % acetonitrile set to pH 3.1 using phosphoric acid. The system contains a solvent 
delivery system (Shimadzu, LC-10AD), an auto-injector (Famos, Spark), a reverse phase 
column (4.6 mm´100 mm, Hichrom, C18, 3.5 mm) and an ESA Coulochem II detector (ESA, 
Bedford, MA, USA) with two electrodes at -40 mV and +320 mV. A conditioning electrode 
with a potential of +40 mV was used to oxidize possible contaminants before analysis. Brain 
stem concentrations of 5-HT, the 5-HT catabolite 5-hydroxyindoleacetic acid (5-HIAA), 
norepinephrine (NE) and the NE catabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) were 
quantified by comparison with standards and corrected for recovery of the internal standard 
using HPLC software (CSW, Data Apex Ltd, the Czech Republic).  
3.8 Radioimmunoassay for Cortisol 
 
Plasma samples were thawed on ice and 100µl aliquots were mixed with 500µl of ethyl 
acetate (Merck KGaA, Darmstadt, Germany) and vortexed for 10 seconds, in order to extract 
steroids into the organic phase, which was then separated by centrifugation for 5 mins at 
8000g at 4⁰C. Thereafter, 50µl of this extract was used for analysis of cortisol content. 50µl 
of [1,2,6,7-3H] cortisol (Amersham Pharmacia Biotech, Little Chalfront, UK, 60 Ci mmol-1) 
diluted in ethyl acetate, was mixed together with the extract and evaporated to dryness under 
vacuum. Donkey anti-cortisol (AbD Serotec, Kidlington, UK) was prepared 1:600 in a 
radioimmunoassay buffer containing 0.1% Bovine Serum Albumin (w/v) (Sigma-Aldrich) 
and phosphate buffered saline (PBS, pH 7.4). 200µl of this antibody solution was added to the 
assay tubes, which were then placed on a rotary shaker for 15mins in 4⁰C. Subsequently, 
samples were left for 18hrs in the dark at 4⁰C. Thereafter, 100µl of a dextran-coated charcoal 
buffer (0.1% dextran (w/v) (Sigma-Aldrich) and 0.5% activated charcoal (Sigma-Aldrich) in 
PBS was added to the tubes, vortexed, and left to stand for 5 min in order to bind free 
steroids. The charcoal was pelleted by centrifugation at 8000g for 10mins at 4⁰C and 200µl of 
the supernatant was transferred into a scintillation tube containing 4ml of Ultima Gold 
scintillation fluid (Perkin Elmer, Waltham, MA, USA). Samples were then counted on a 
Packard Tri-Carb A1900 TR liquid scintillation analyzer (Packard Instrument, Meriden, CT, 
USA). 
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A 3-parameter hyperbolic function was fitted to the plot of the percentage of 3H-cortisol 
bound against a standard curve using SigmaPlot 11 (SPSS Science, Systat Software Inc., San 
Jose, CA, USA). All samples were run in duplicate. Samples were reran, in cases were values 
fell outside the standard curve, with a more appropriate amount of extract.. 
3.9 Video Analysis 
 
Video recordings taken during feeding times were used to characterize behavior. However, no 
data was taken during actual feeding. That is, the quantification of swimming behavior was 
done when fish were undisturbed. In order to quantify the tendency to stay at the top of the 
water column, total time spent in this section, during a 5 min period, beginning 5 min after the 
room door was opened, was analyzed. Many fish species avoid spending too much time at the 
water surface, since it leaves them more vulnerable to possible predator attacks56. Therefore, 
total time spent near the surface, has been commonly used as a metric in order to assess 
normal/aberrant behavior50,57,58. The head up tail down positioning was defined as a behavior 
where the fish was angled more than 45⁰ upwards while not engaged in locomotor activity. 
Even though the camera arrangement did not allow for quantitative measurements of fish 
body posture, video recordings were sufficient to distinguish the display of this particular 
behavior. Therefore, each fish was classified as either showing or not showing this head up 
tail down behavior on the day before terminal sampling (day 17 of the experiment). 
3.10 Statistical Analysis 
 
All statistical analysis was performed on Graphpad Prism 6 (Graphpad Software, San Diego, 
CA, USA). Data on surfacing behavior and body weight was analyzed by Repeated Measures 
ANOVA and differences between groups on each day were confirmed by a Tukey post-hoc 
test. Data on head up tail down behavior was analyzed by Fisher’s Exact Test. Normality was 
assessed by means of a D'Agostino-Pearson test and values were either log or arcsine 
transformed if necessary. Cortisol, heart size, brain stem neurochemistry and quantitative 
PCR values, were analyzed by means of a Student’s t-test or Welch’s t-test (non-parametric 
data). Data sets were subjected to Grubbs test in order to detect possible outliers at α = 0.01. 
Differences were considered significant at p < 0.05. 
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4 Results 
4.1 Behavioral Observations 
4.1.1 Feeding behavior 
 
Fluoxetine treatment over several days decreased feeding behavior, as depicted in Figure 2. 
The increasing reluctance of fluoxetine treated fish to seek and ingest pellets was especially 
evident after 11 days of treatment, at which point oral delivery of fluoxetine via food had to 
be changed to i.p. delivery. Furthermore, from day 15 of treatment until the end of the 
experiment most of the fluoxetine-treated group did not respond at all to food (neither shrimp 
nor dry pellets). Note that control fish maintained normal feeding behavior throughout the 
experiment, even after receiving i.p. saline injections.  
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Figure 2: Fluoxetine decreased response to food in Atlantic salmon 
Percentage of individuals in each group accepting food. (n = 15 for control, n = 13 for fluoxetine). 
 
4.1.2 Positioning in the water column 
 
After 9 days exposure to fluoxetine, treated fish showed an increased tendency to place 
themselves in a head up, tail down position. That is, they were inclined with the head higher 
up in the water column than the tail, as depicted on Figure 3A. Importantly, this behavior was 
only evident in the fluoxetine-treated group. After 17 days of exposure to fluoxetine, the head 
up, tail down position was observed in 12 out of 13 fluoxetine treated fish, but none of the 15 
control fish (p < 0.0001). Fluoxetine treated fish also showed a greatly increased tendency to 
place themselves in the top half of the tank (p < 0.0001) (Figure 3B). 
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Figure 3: Altered water column and body positioning in Atlantic salmon 
A) Video frame showing tendency of fish to place themselves with a head up/tail down position high in the water column. (p < 0.0001) B) 
Total time(s) spent during 5 min at top half of the tank. Presented as means ± S.E.M. (n = 15 controls, n = 13 fluoxetine) , F (9, 234) = 22.87, p 
< 0.0001 
 
4.2 Physiological Parameters 
4.2.1 Blood plasma cortisol 
 
Treatment with fluoxetine significantly increased cortisol levels compared to controls (Figure 
4; p = 0.0003).  
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Figure 4: Fluoxetine treatment increased plasma cortisol levels in Atlantic salmon 
Mean plasma concentrations of cortisol (± S.E.M.) for control (n = 15) and fluoxetine (n = 11) treated fish. Welch’s t-test: t(12.46) = 5.01; p < 
0.0001. 
 
4.2.2 Cardiosomatic index (Ventricle Weight/Body Weight) 
 
Fluoxetine treatment significantly increased the cardiosomatic index (CSI; Figure 5, p = 
0.024). Importantly, this increase was not caused by a difference in body weight between the 
A) 
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groups, since there were no significant differences between groups neither at the start (p = 
0.2144), nor at the end of the experiment (p = 0.9712).  
 
Figure 5: Fluoxetine treatment increased CSI in Atlantic salmon 
A) Mean cardiosomatic index (CSI, ± S.E.M) for control (n = 14) and fluoxetine fish (n = 11) at the end of the experiment. Students t test: 
t(23) = 2.491; p = 0.024  
 
4.2.3 Brain Stem Neurochemistry  
 
The concentration of 5-HIAA in the fluoxetine-treated group was significantly increased 
compared to controls (Figure 6A, p = 0.0041). Meanwhile 5-HT levels in the fluoxetine-
treated group were significantly lower than controls (Figure 6B, p < 0.0001). Consequently, 
the [5-HIAA]/[5-HT] ratio was also significantly increased in the fluoxetine-treated group 
compared to controls (Figure 6C, p = 0.0008).  
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Figure 6: Fluoxetine altered serotonergic signaling in Atlantic salmon after 17 days of exposure. 
Mean concentrations (± SEM) in brain stem of 5-HIAA, 5-HT and the [5-HIAA]/[5-HT] ratio for control (n = 15) and fluoxetine (n = 12) 
fish. Students t test statistics: A) t(13.83) = 3.428; p = 0.0041. B) t(25) = 4.546; p < 0.0001. C) t(12.16) = 4.408; p = 0.0008 
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Treatment with fluoxetine also significantly increased the concentration of MHPG in the brain 
stem as compared to controls (Figure 7A, p = 0.0056). However, NE levels were found to be 
similar between groups (Figure 7B, p = 0.6744). Meanwhile, the [MHPG]/[NE] ratio was 
significantly increased in the fluoxetine-treated group compared to controls (Figure 7C, p = 
0.0086). 
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Figure 7: Fluoxetine increased norepinephrine signaling in Atlantic salmon 
Mean concentrations (± SEM) in brain stem of MHPG, NE and the [MHPG]/[NE] ratio for control and fluoxetine fish. Students t test 
statistics: A) t(10.21) = 3.491; p = 0.0056; ncontrol = 13, nfluoxetine = 9. B) t(24) = 4.254; p = 0.6744; ncontrol = 15, nfluoxetine = 11. C) t(13) = 3.019; p = 
0.0086; ncontrol = 13, nfluoxetine = 9. 
 
4.2.4 Hypothalamic relative gene expression 
 
Fluoxetine treatment significantly increased hypothalamic AVT (Figure 8A, p = 0.0402) and 
5-HT1Aβ (Figure 8B, p = 0.0384) mRNA levels. Note that significance of 5-HT1Aβ was 
contingent on the removal of one outlier (Grubbs, α = 0.01) from the control group.  
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Figure 8: AVT and 5-HT1Aβ hypothalamic mRNA levels are increased by fluoxetine treatment 
Average (± SEM) mRNA levels of AVT and 5-HT1Aβ relative to the reference gene EF1α in hypothalamus of control (n = 15) and fluoxetine 
(n = 12) fish. Students t statistics: A) t(25) = 2.164; p = 0.0402. B) t(16.39) = 2.251; p = 0.0384. 
No significant differences were found between treatment groups on hypothalamic relative 
mRNA levels of CRH, MR, GR1, GR2, SERT, 5-HT1Aα, PCNA or BDNF (Table 2).  
Table 2: Average (± SEM) mRNA levels of Corticotropin Releasing Hormone (CRH), Mineralocorticoid Receptor (MR), Glucocorticoid 
Receptor 1 (GR1), Glucocorticoid Receptor 2 (GR2). Serotonin Transporter (SERT) and 5-HT1Aα relative to the reference gene Elongation 
Factor 1α (EF1α) in hypothalamus of control (n = 15) and fluoxetine (n = 12) fish. 
Gene Control  Fluoxetine  t-statistic p-value 
CRH 0.027 (±0.00348) 0.027 (±0.00178) t(20.47) = 0.00797 0.99 
MR 0.0001103 (±0.000022) 0.00012 (±0.000023) t(25) = 0.2691 0.79 
GR1 0.00037 (±0.000044) 0.00047 (±0.000043) t(25) = 1.622 0.1174 
GR2 0.007469 (±0.000822) 0.008835 (±0.001585) t(25) = 0.8102 0.4254 
SERT 0.00233 (±0.00042) 0.0031 (±0.00073) t(25) = 0.9553 0.3486 
5-HT1Aα 0.01166 (±0.001564) 0.01383 (±0.00196) t(25) = 0.8798 0.3874 
PCNA 0.1178 (±0.01166) 0.1028 (±0.00607) t(20.68) = 1.142 0.2664 
BDNF 0.05212 (±0.006523) 0.05117 (±0.004589) t(25) = 0.1136 0.9105 
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5 Discussion 
 
In the present experiment I found that fluoxetine treatment affected not only the behavior of 
Atlantic salmon, but also a range of physiological parameters that could be linked to 
behavioral and endocrine stress responses. In brief, it was observed that fluoxetine decreased 
receptiveness to food, increased time spent high up in the water column and their tendency to 
be positioned with their heads elevated. Physiologically, plasma cortisol and the relative heart 
size were found to be significantly increased. Furthermore, as adjudged from neurochemical 
analysis, brain stem serotonergic and noradrenergic activity was increased in fluoxetine 
treated fish. Finally, in the hypothalamus, relative mRNA expression levels of the 
neuropeptide AVT and the serotonin receptor 5-HT1Aβ were also significantly increased.    
5.1 Activity of the HPI axis 
 
Administration of fluoxetine would appear to have induced an activation of the HPI axis in 
Atlantic salmon, as indicated by plasma cortisol levels. Plasma cortisol concentrations were 
found to be elevated by a factor of 5 (approximately) in fluoxetine-treated fish, which is 
comparable to cortisol responses obtained after acute stress in salmonid fishes23,59. 
Considering the effect of fluoxetine on the serotonergic system (discussed further below), the 
fluoxetine-increased cortisol levels are  in agreement with previous findings regarding a 
stimulatory effect of 5-HT activation on HPI axis activity in comparative models. For 
example, in the Gulf toadfish (Opsanus beta)45 and Arctic charr (Salvilinus alpinus)44, 
administration of an 5-HT1A  receptor agonist induces a cortisol response. Furthermore, 
plasma cortisol responsiveness to stress has been reported to be positively associated with 
heart size in rainbow and brown trout60. In previous experiments in this lab on rainbow trout, 
21 and 45 days of oral cortisol administration induced a significant CSI increase of 20% and 
24% respectively, while shorter treatments of up to 7 days appeared not to have an effect on 
the CSI61. In the present experiment, we found that fluoxetine-treated fish had a 13.8% larger 
CSI compared to controls, suggesting that the HPI axis activation could have been sustained 
over many days. Both central and peripheral mechanisms could have caused the simultaneous 
increase of cortisol and CSI, as fluoxetine treatment is also known to increase plasma 
serotonin levels62, which were not measured in this experiment. For example, a peripheral 
mechanism may act through the 5-HT2A receptor activity, which are found to be expressed in 
cardiomyocytes and mediate cardiac hypertrophy in murine cardiac disease models60,63,64 
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through the calcineurin/NFAT pathway. Similarly, peripheral 5-HT1A receptors in the head 
kidney of goldfish (Carassius auratus) capable of stimulating cortisol production have been 
reported65, but the receptor abundance varies greatly between teleost species45. Disregarding 
the specific mechanism at hand, fluoxetine treatment increases not only cortisol levels but 
also heart size in salmon after 2 weeks treatment. Furthermore, both these results indicate an 
increased activity of the HPI axis, possibly over several days. 
CRH and AVT (the teleost homolog of AVP) are neuropeptides that play a central activating 
role in the HPI axis.. As mentioned in the introduction, CRH and AVT induce pituitary 
release of ACTH which triggers cortisol production from the interrenal cells66,67. Fluoxetine 
treated salmon showed similar transcript levels of CRH in the hypothalamus compared to 
controls. Although speculative, the measured elevated cortisol levels may have suppressed 
CRH mRNA levels at the timepoint of sampling, as CRH transcription is known to be under 
negative feedback control via the glucocorticoid receptor acting on GREs in teleost fish68 and 
mammals30. mRNA transcript levels of both teleost paralogs of the glucocorticoid receptor 
and the putative mineralocorticoid receptor in the hypothalamus were similar between 
treatment groups, hence glucocorticoid-receptor signaling was not affected by fluoxetine. 
However, I did not find any relationship between cortisol levels and CRH expression in the 
hypothalamus (results not shown). Notably, it has been reported that glucocorticoid-induced 
suppression of CRH transcription is region-specific and that hypothalamic CRH is not 
necessarily downregulated by cortisol69. If the assumption is made that transcript levels of 
CRH in the hypothalamus are reflective of signaling levels of CRH down the HPI axis, then it 
is possible that in the current experiment CRH was not the cause of the elevated cortisol 
levels in fluoxetine-treated salmon. This is in contrast to the findings of Mennigen et. al70 
where fluoxetine treatment in goldfish, at a similar averaged daily dose every 3 days for 2 
weeks, increased hypothalamic CRH mRNA. The discrepancy might be attributed to the 
different dose timings used (i.e. every 2 days in the current experiment vs. 3 days in theirs).  
On the other hand, mRNA levels of AVT in the hypothalamus were found to be significantly 
elevated in fluoxetine-treated fish. AVT, apart from independently stimulating ACTH 
release71 and negatively regulating appetite in fish72 and mammals30, also has a potentiating 
effect on CRH function in salmonids71. In mammals, CRH and AVP neurons in the 
paraventricular nucleus of the hypothalamus are under direct control by serotonergic signaling 
through the 5-HT2A/C and 5-HT1A receptors
38,73. Therefore, it is possible that AVT could have 
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been the mechanism of HPI axis activation in fluoxetine-treated fish, induced by an increased 
5-HT signaling to fluoxetine administration. In teleosts, central administration of AVT in 
isolated rainbow trout induced sizable increases in mean plasma cortisol concentrations72,74.  
In addition, Gesto et al.72 found increased serotonergic activity in the hypothalamus and the 
telencephalon in response to central administration of AVT, which the authors cite as 
evidence of bidirectional crosstalk between AVT signaling and serotonergic activity. In 
contrast to the results found in the present experiment, blue head wrasse (Thalassoma 
bifasciatum), administered fluoxetine daily for 2 weeks, had a decreased expression of AVT 
in the anterior hypothalamus75. This discrepancy may be the product of dose-dependent 
effects, as the averaged daily dose administered by Semsar et. al.75 was three-fold higher than 
in my experiment. It is possible that different doses of fluoxetine have different effects, as the 
presynaptic 5-HT receptors appear to have greater sensitivity to 5-HT signaling46. In addition, 
the relatively more stressful regime of daily injections used by Semsar et. al.75 may have 
caused a compensatory downregulation of AVT mRNA similar to that found in rainbow trout 
subjected to repeated stress76. 
5.2 Feeding Behavior 
 
An anorectic effect of both acute and chronic fluoxetine administration is documented in 
humans37, murine models37,77,78 and in teleosts58,70. In the present experiment, the response to 
food in Atlantic salmon was decreased after exposure to fluoxetine. This decline was 
particularly marked following the switch from oral to i.p. administration, perhaps due to 
increased bioavailability of fluoxetine. Importantly, I do not believe that the decrease in food 
consumption was due to the stressfulness of i.p. injections, since this did not seem to affect 
the appetite of vehicle-injected controls (see below for the implications of the switch in mode 
of administration). Furthermore, the switch from oral to i.p. administration was made because 
of an increasing reluctance of fluoxetine-treated salmon to accept food, which is further 
evidence that the anorectic effect was not specific to the mode of administration. Also, the 
fluoxetine treated salmon refused both untreated food pellets and treated shrimp, 
demonstrating that anorectic behavior was not due to aversive taste conditioning. Feeding 
behavior in mammals and teleosts is under reciprocal control of a feeding and a satiety center, 
located in the hypothalamus48 and innervated by serotonergic fibers37. A diverse array of 
orexigenic and anorectic CNS and peripheral neuropeptides modulate feed intake79. In 
teleosts, a common consequence of stress is a disruption in feeding behavior, an elevation of 
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serotonergic activity and an activation of the HPI axis66. Interestingly, CRH and AVT have 
been shown to modulate both the HPI axis and feeding behavior by independent 
mechanisms80,81.  
The mechanisms mediating the anorectic response in the present experiment to fluoxetine are 
still unclear. Direct serotonergic signaling to the hypothalamus feeding centers mediated 
through 5-HT1B and 5-HT2C receptors is one possible mechanism for anorexia which has been 
described in murine models, along with the action of 5-HT on peripheral receptors37. Central 
effects of serotonergic signaling on appetite in teleosts have also been demonstrated, but 5-
HT1A and 5-HT2C appear to be involved, while 5-HT1B is not
34. AVT signaling triggers 
transcription of 2 anorectic neuropeptides, CART and α-MSH (derived from POMC)72. 
Anorexia as a result of fluoxetine administration in goldfish has also been previously 
reported70, probably induced via CRH.  
In addition, the neuropeptides CRH and AVT are also potent activators of the HPI axis as 
discussed above. As elevated cortisol levels were seen in the present experiment in the 
anorexic group, it would be relevant to consider the possible contribution of elevated cortisol 
to this anorexic effect observed in fluoxetine-treated fish. In mammals, moderately elevated 
plasma cortisol levels have orexigenic effects82. Similarly, stress-induced cortisol elevation 
has been linked to a reduction in feed intake in many teleost studies. These studies are 
complicated by the fact that the stressors used, such as social or confinement stress can 
regulate via serotonin and/or neuropeptides (e.g. CRH) feeding behavior independent of 
cortisol80. In two rainbow trout studies, exogenously administered cortisol induced a loss of 
appetite83,84. The interpretation of one of these studies has however been questioned, as there 
was significant aggression found among the cortisol-treated cohort which might have been the 
cause of anorexia, rather than cortisol80. On the other hand,  Øverli et. al.85 report no such 
reduction in feed intake during oral administration of cortisol to rainbow trout. However, 
published and unpublished results from our lab indicate that direct oral administration of 
cortisol to isolated rainbow trout have found  no reduction over short periods of time (e.g. 2-4 
days), but significant reductions in food intake over longer periods (7-21 days) at plasma 
cortisol concentrations comparable to levels found under chronic social subordination86. 
Furthermore, Nørstrud et. al.61 reports that the observed reduction in food intake was 
associated with a “spitting” behavior, whereby the fish would attempt to eat the food, but 
were apparently unable to swallow. This was distinct from the present experiment, where no 
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attempts to eat  food were seen at all in long term fluoxetine-treated fish. While the possibility 
cannot be excluded that the fluoxetine-induced anorexia in the present experiment was a 
cortisol-induced effect, the dramatic reductions of feeding behavior seen in contrast to cortisol 
administration studies suggest that 5-HT mediated AVT signaling could be a more likely 
mechanism.  
5.3 Monoamine signaling and behavior 
 
In addition to decreased feeding behavior, there were two other, possibly closely related 
behavioral responses which emerged in the fluoxetine-treated salmon group. The first was a 
dramatic increase in time spent at the top half of the water column (described in the literature 
as a surfacing behavior51 reduced geotaxis87 or top-dwelling51) while the second was a 
tendency to be positioned “head up, tail down” at a near vertical angle. These two behavioral 
phenotypes have been observed in other studies involving the serotonergic system, either 
separately or together. Surfacing behavior after fluoxetine treatment has been reported in 
mosquitofish (Gambusia affinis)50, hybrid striped bass (Morone saxatilis x M. chrysops)58 and 
several zebrafish87 studies. This is however inconsistent as other studies have also reported 
contrary results57. Furthermore, the “head up, tail down” behavior has also been observed in 
the mentioned hybrid striped bass experiment after fluoxetine treatment58. 
Even though the mechanisms that underlie these behavioral responses to fluoxetine treatment, 
are still unknown, it might be possible that these behaviors are evidence of 5-HT toxicity 
elicited by massive drug-induced overdoses that do not occur physiologically. Stewart et. al.51 
supports this argument, and considers these behaviors as teleost correlates of the 5-HT 
syndrome. The 5-HT syndrome has been described in mammals under similar circumstances, 
such as during an SSRI overdose or when two or more serotonin-perturbing treatments are 
administered together. Herculano et. al.87 points out, however, that even though 5-HT toxicity 
cannot be excluded, in some cases smaller doses were more effective at eliciting surfacing 
behavior than much larger doses.  
Interestingly, subordinate farmed Atlantic salmon subjected to chronic social stress (inferred 
from physiological parameters) display a surfacing, head up tail down and anorectic 
behavioral phenotype very similar to that observed in the present experiment2. In addition, 
cortisol and brain 5-HT parameters in these fish were found to be elevated compared to 
normally behaving control fish under basal conditions27. Surfacing and head up tail down 
26 
 
behavior has also been seen in subordinate rainbow trout and Arctic charr after a single dyadic 
contest, commonly displayed after receiving high levels of unilateral aggression from the 
dominant (Riise & Øverli, unpublished observations). Subordination in a dyadic contest in 
rainbow trout and Arctic charr is known to increase serotonin turnover in the brainstem (and 
other regions)23,24. Extrapolating these findings (which are similar to those found in rats88) to 
zebrafish and/or Atlantic salmon, we can speculate that physiologically relevant levels of 
serotonergic activity may be capable of producing the surfacing, head up tail down behavioral 
profile exhibited in the current experiment.  
In the present experiment, indicators of serotonergic and norepinephrine activity were 
increased by fluoxetine treatment. Increased 5-HT and NE activity has been associated with 
generally stressful situations20 such as social subordination23 and nonsocial stressors89. 
Therefore, it appears that the physiological and behavioral profile of a fish undergoing 
chronic social stress strongly resembles the physiological (i.e. increased cortisol, relative heart 
size, 5-HT and NE activity) and behavioral (increase in surfacing, head up tail down and 
anorectic behavior) profile exhibited by the fluoxetine-treated salmon in this experiment.   
Even though the neurochemical profile of the salmon in the current experiment bear strong 
similarity to that of chronically subordinate fish, the possibility cannot be dismissed that 5-
HT1A autoreceptors might also have been strongly activated on serotonergic neurons of the 
hypothalamus. In the hypothalamus, the serotonin receptor 5-HT1Aβ was upregulated while 5-
HT1Aα was not. This upregulation could suggest that neurons expressing 5-HT1Aβ were 
preferentially active compared to those expressing 5-HT1Aα. In mammals, the expression of 5-
HT1A in neuronal cells is negatively regulated by Freud1 and Freud2 repression factors
43. 
Freud1 and Freud2 are in turn negatively regulated by intracellular calcium90,91, which could 
come from voltage-gated calcium channels or intracellular calcium stores during activity92,93. 
A presynaptic upregulation of the autoreceptor decreases serotonergic tone, while a 
postsynaptic upregulation increases serotonergic signaling. From these data, it is however not 
possible to speculate on the identity (presynaptic serotonergic or postsynaptic, non-
serotonergic, possibly neuropeptidergic) or outgoing transmission of the 5-HT1Aβ expressing 
neurons. It is interesting to note that a genotype indicative of 5-HT vulnerability to depression 
(C(-1019)G(rs6295)Htr1a), is predicted based on murine models to result in increased 5-HT1A 
autoreceptor expression on serotonergic raphe cells43. Thus, the 5-HT1Aβ upregulation in the 
current experiment may be a precursor to pathology. 
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The role of fluoxetine treatment on SERT mRNA levels in the raphe nuclei reported in the 
mammalian literature describe mixed effects, either upregulation, downregulation, or no 
changes94. Furthermore, in teleosts, the transcriptional response of SERT to fluoxetine has not 
yet been characterized. Therefore the interpretation of the results obtained in the present 
experiment (no change in SERT mRNA levels in the hypothalamus), remains to be 
elucidated.  
5.4 Markers of Neurogenesis and Neuroplasticity 
 
The modulation of neurogenesis and neuroplastic markers in teleosts in response to 
environmental stimuli is thought to follow a biphasic U-shaped curve, where mild and/or 
acute stress are stimulatory and severe and prolonged stress are inhibitory95. For example in 
rainbow trout subjected to chronic social stress, cell proliferation in the telencephalon is 
decreased25. One of the proposed mechanisms modulating neurogenesis in mammals96 as well 
as in teleosts86 is cortisol. While cortisol levels of fluoxetine treated Atlantic salmon in the 
current experiment were significantly elevated to levels comparable to chronic stress54, no 
effects on mRNA levels of the cell proliferation marker PCNA or the neurotrophic peptide 
BDNF were found in the hypothalamus. As only a single time point was sampled, it is not 
possible to establish if the lack of change was maintained throughout the experiment or if it 
had crossed the biphasic curve described in Sørensen et. al.95.  
5.5 Experimental Considerations 
 
In the administration of fluoxetine to salmon in the current experiment, there are two 
considerations that may have affected the results, or the interpretation thereof. The first is an 
interruption of treatment early on in the experiment. Due to logistical issues, the time between 
the first and the second dose of the drug was 5 days, instead of 2 days as was maintained for 
the remainder of the experiment. The half-life of fluoxetine is 2 days in humans52 and 15hrs in 
rats97 at the start of treatment. In hybrid striped bass, 6 days of recovery after 6 days of 
immersion treatment (100µg/L) is sufficient for 5-HIAA concentrations in the brain to recover 
to pre-exposure levels58. While it is difficult to compare immersion doses with i.p. 
administration doses, it would be prudent to consider the primary time course of treatment as 
a 12 day treatment, starting on Day 5 of the experiment. If the pharmacokinetics of 
elimination in Atlantic salmon are similar to mammals, it is also of note that fluoxetine 
inhibits its own metabolism, causing the half-life in humans to rise from 2 to 6 days after 
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multiple treatments52. It is unlikely but cannot be excluded that the initial dose affected 
metabolism of the subsequent treatments as a small amount of fluoxetine might still be 
present after 5 days, thus accelerating the appearance of the behavioral phenotypes observed.  
The second consideration is the switch from oral to i.p. administration at Day 11 of the 
experiment, necessitated by the increasing reluctance to accept food. Orally administered 
fluoxetine is subject to extensive first-pass metabolism by the liver, with only 38% reaching 
general circulation in humans52. To our knowledge, no studies on the oral bioavailability of 
fluoxetine in teleosts have been done, as ecotoxicological studies are focused on the gills as 
the most likely mode of entry. On the assumption that first-pass metabolism in the liver by 
Atlantic salmon removes a significant, but unknown proportion of orally administered 
fluoxetine, the behavioral data could be considered a preliminary evaluation of dose-
dependent effects, with higher effective doses producing stronger effects. Notably, all 
behavioral effects reported were also observed to a lesser degree prior to the switch in 
administration. Thus, the behavioral effects described here appear not to be specific to the 
mode of administration.  
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6 Conclusions and Future Perspectives 
 
Delivery of the drug fluoxetine in food to Atlantic salmon using rehydrated shrimp was 
partially successful, as long term treatment induced loss of appetite. Oral administration of 
exogenous substances incorporated in food is a relatively stress-free mode of administration, 
which is important when attempting to study the stress response, as habituation or 
sensitization to a repeated procedural stressor may alter or mask treatment effects. In future 
work, oral delivery of any substance raises the consideration of first-pass metabolism by the 
liver. These effects cannot be dismissed by current behavioral data, especially since stronger 
effects were seen after the switch to i.p. administration, even though the nominal dose 
delivered was unchanged. A possibility that there was an interaction between drug and 
injection procedure cannot be excluded. 
In the current experiment, Atlantic salmon treated with fluoxetine for 2 weeks show an array 
of physiological and behavioral responses that seem to parallel those observed in conditions 
of chronic stress. The hypothalamic neurogenic markers however, appear not to be affected by 
fluoxetine treatment. This experiment was done in social isolation, with no external stressor 
or social interaction applied. A likely interpretation then is that the serotonergic activity seen 
during social stress may be the primary driver of many physiological and behavioral 
responses to social subordination. Notably, a 5-HT1Aβ upregulation was found in the 
hypothalamus. Given the central integrating role of the hypothalamus in the regulation of the 
stress response, it is of particular interest to elucidate whether this upregulation is specific to 
autoreceptors in serotonergic neurons (which reduces serotonergic tone), or on target neurons 
which mediate downstream effects of serotonergic signaling. It is also striking that social 
interactions are not required to elicit behavioral responses that are remarkably similar to those 
elicited under social stress. This suggests that the head up tail down and surfacing behaviors 
reported by Vindas et. al.27 in Atlantic salmon and Riise & Øverli (Riise & Øverli, 
unpublished) in subordinate Arctic charr and rainbow trout, may not be conditioned responses 
to species-typical aggression, but rather a more generalized response to severe stress. 
However, the stress response is highly interconnected and it is thus difficult to disentangle the 
causative roles of each component under conditions with an external stressor. Therefore, 
manipulation of specific components of the same, in the absence of a stressor, may allow 
dissociation of each component under experimental conditions.  
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As the resolution of the current experiment is relatively broad, a more detailed examination of 
these specific results should be attempted. For example, investigation of the specific 
localization of the 5-HT receptor upregulation could yield information on specific neuronal 
populations that are affected. Also, suitable in-vivo molecular and genetic methods, such as 
calcium imaging and transgenic lines, may be of use in a finer-grained examination of neural 
circuitry involved in the behavioral responses. In addition to exploring the current results in 
greater detail, another venue of inquiry could focus on elucidating more of the similarities and 
differences in behavior and physiology between pharmacological and stressor-induced 
serotonergic activity in the brain. A third line of questioning could seek to understand the 
mechanisms behind the heart size increase in fluoxetine treated animals, as it is not clear if 
this is caused by central or peripheral mechanisms. 
In conclusion, this study shows that fluoxetine treatment of Atlantic salmon for 18 days 
induces heightened serotonergic and noradrenergic activity in the brain stem, causes behavior 
that is similar to that observed in highly stressed salmonids, increases heart size, activates the 
HPI axis and upregulates a 5-HT receptor that is closely associated with affective disorders in 
the hypothalamus. This illustrates how comparative animal models may be used to discern the 
mechanisms involved in pharmacological manipulation of brain systems. 
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